Eman NasrEldin

Eman NasrEldin

Auto-generated profile, based on publicly available information

Eman NasrEldin

Clinical Pathology Department, Faculty of Medicine, Assiut University, Assiut, Egypt

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2014 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
SHSherifa A. Hamed
Sherifa A. Hamed
EMEhab M. M. Moussa
Ehab M. M. Moussa
AYAhmad H. Youssef
Ahmad H. Youssef
MEMohammed A. Abd ElHameed
Mohammed A. Abd ElHameed
ENEman NasrEldin
Eman NasrEldin
Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 matched healthy controls. Bone mineral content (BMC) and densities (BMD) of the femoral neck and lumbar spine were measured using dual energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor kB ligand (sRANKL), osteoprotegerin (OPG) and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score and T-score at the femoral neck and lumbar spine (all p<0.001). 72% and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D and OPG and higher ALP, sRANKL levels and sRANKL/OPG (all p<0.001). 52% of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p=0.043; p=0.010), duration of treatment with AEDs (p<0.001; p=0.012) and serum levels of 25(OH)D (p<0.042; p=0.010), sRANKLs (p=0.005; p=0.01) and OPG (p<0.006; p<0.01). In linear regression analysis and after adjusting for gender, age, weight, duration and number of AEDs, we observed an association between BMD, 25(OH)D (p=0.04) and sRANKL (p=0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms.

1 September 2020 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
SSSafaa Safaa
Safaa Safaa
ENEman NasrEldin
Eman NasrEldin
YMYasmine Makarem
Yasmine Makarem
Hamdy MahmoudHamdy Mahmoud
Hamdy Mahmoud
Background and Objective: Disease activity score 28 (DAS28) for rheumatoid arthritis (RA) is the commonly used DAS; it relies on clinical parameters that could be subjective. This work aimed to create a more accurate DAS for RA and assess its validity. Patients and Methods: The study included 98 RA patients and 53 matched controls; they were interviewed, clinically examined, their visual analogue scales (VAS) were reported, and then blood samples were withdrawn for erythrocyte sedimentation rate (ESR), complete blood count (CBC), and C-reactive protein (CRP). Platelet indices (PIs) were obtained from the CBC including Plt (platelet count), mean platelet volume (MPV), platelet distribution width (PDW) and plateletcrit (PCT). DAS28 was calculated for each patient using RheumaHelper mobile software. Minitab Statistical Package® and SPSS v20 software were used for data analysis. Results and Conclusions: Results revealed perfect matching between patients and controls as regarding age and gender. ESR, CRP and PDW were significantly higher in patients than controls; also positive correlations were detected among these variables. A new DAS for RA was developed; ESR, CRP, PDW and MPV were the components for this index. Further analyses showed that this new score was significantly higher in patients than controls and correlated with DAS28 of the patients. Furthermore the new score could identify RA patients from healthy subjects (cut off value < − 0.79) and stratified RA patients according to their disease activity into low, intermediate, high, or in remission. Conclusively, we developed a more precise, easily obtained new DAS for RA. This new DAS has both diagnostic/prognostic values in patients with RA.

1 January 2013
Verified
Journal Article
Open access
FFFahim M. Fahim
Fahim M. Fahim
Khaled SaadKhaled Saad
Khaled Saad
EAEman A. Askar
Eman A. Askar
EEEman Nasr Eldin
Eman Nasr Eldin
ATAhmed F. Thabet
Ahmed F. Thabet
The aim of this study is to assess the growth parameters, vitamin D, calcium, and phosphorous status in children with thalassemia major receiving packed red cells transfusion with chelation therapy. In a case control study, 100 patients with beta thalassemia major (aged from 4 to 15 years) were compared with 100 sex- and age-matched children serves as a control group. Anthropometric measurement, Serum level of calcium, phosphorus and vitamin D (25 hydroxycholecalciferol) were estimated for all patients & controls. 49% of our patients had short stature. 47% were underweight. BMI of 43 (43%) patients were low. The mean total serum calcium (6.6±1.2 mg/dl) and 25-hydroxycholecalciferol (25-OH Vit D) (10.4±4.6 mcg/dl) levels were significantly lower in our patients than in controls (10.2±1.06 mg/dl and 40.2±12.3 mcg/dl, respectively); each P< 0.001. Children with beta thalassemia major have delayed growth and metabolic abnormalities that signify the importance of therapeutic interventions. The presence of these abnormalities may be due to iron overload and poor nutritional support.

1 February 2015 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
SHSherifa A. Hamed
Sherifa A. Hamed
BHBruce P. Hermann
Bruce P. Hermann
EMEhab M.M. Moussa
Ehab M.M. Moussa
AYAhmad H. Youssef
Ahmad H. Youssef
TRTarek A. Rageh
Tarek A. Rageh
ENEman NasrEldin
Eman NasrEldin

4 May 2012 in Hepatology International
Verified
Journal Article
Closed access
PDF file
HMHoda A. Makhlouf
Hoda A. Makhlouf
KMKhairy Hammam Morsy
Khairy Hammam Morsy
NMNahed A. Makhlouf
Nahed A. Makhlouf
EEEman Nasr Eldin
Eman Nasr Eldin
MKMahmoud Khairy
Mahmoud Khairy

1 July 2015 in The Egyptian Journal of Chest Diseases and Tuberculosis
Verified
Journal Article
Open access
HSHala Mohamed Shalaby Samaha
Hala Mohamed Shalaby Samaha
AEAmany Ragab Elsaid
Amany Ragab Elsaid
ENEman NasrEldin
Eman NasrEldin
ObjectiveThe Dutch Hypothesis has been used to suggest that Asthma and COPD may be considered as different expressions of one disease entity. The purpose of this study is to evaluate the levels of IgE in COPD patients and its relation with respiratory symptoms and lung functions this may be a suggestive of atopy as a mechanism for initiation of their exacerbations.MethodsA cross-sectional case-control study was conducted on 50 subjects recruited from the outpatient clinic (11 healthy volunteers, 39 diagnosed as COPD) COPD patients (31 males (79%) and 8 females (21%)) diagnosed as mild, moderate and severe. The studied groups were also divided according to total serum IgE levels and compared in demographic data, clinical data, spirometric data, and HRCT findings.ResultsCOPD patients with elevated IgE had a longer history of illness, high smoking index, higher number of exacerbation in the last year, and more lower FEV1.HRCT finding in both groups was hyperinflation was high in COPD patients with normal IgE levels, 10 cases (45%), while bronchiectasis was higher in COPD patients with elevated IgE, 7 cases (41%). Sputum culture was positive for aspergillosis in 5 cases (29%) in COPD patients with elevated IgE.ConclusionsThere was a high prevalence of elevated serum T-IgE in patients with COPD but without obvious atopy. Serum T-IgE levels were found to be associated with symptoms such as dyspnea and impairment of lung function. Recurrent exacerbation of COPD is believed to accelerate disease progression and impairment of pulmonary function